CXCR2 and Other metabolic disease: Further in vivo studies discovered using mouse models that inducting CXCR2 was found to worsen steatohepatitis [41] and antagonizing CXCR1 and CXCR2 protected mice from metabolic disease by a modulation of the inflammatory process [42].